CD28-Autoantibodies in Melanoma patients - a new prognostic Marker?

被引：0
|
作者：
Schmaltz, R. [1 ]
Madjidi, D. [1 ]
Preuss, K.-D. [2 ,3 ]
Mueller, C. S. [1 ]
Pfreundschuh, M. [2 ,3 ]
Graeber, S. [4 ]
Vogt, T. [1 ]
Pfoehler, C. [1 ]
机构：
[1] Univ Klinikum Saarlandes, Klin Dermatol Venerol & Allergol, Homburg, Germany
[2] Univ Klinikum Saarlandes, Innere Med Klin 1, Homburg, Germany
[3] Univ Klinikum Saarlandes, Jose Carreras Zentrum Immun & Gentherapie, Homburg, Germany
[4] Univ Klinikum Saarlandes, Inst Med Biometrie Epidemiol & Med Informat, Homburg, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [1] Autoantibodies against CD28-a new prognostic marker in malignant melanoma with impact on therapies with interferons?
    Schmaltz, R.
    Madjidi, D.
    Preuss, K.
    Mueller, C.
    Pfreundschuh, M.
    Vogt, T.
    Pfoehler, C.
    EXPERIMENTAL DERMATOLOGY, 2011, 20 (02) : 196 - 196
  • [2] Serum Antibodies against CD28-A New Potential Marker of Dismal Prognosis in Melanoma Patients
    Koerner, Rebecca
    Preuss, Klaus-Dieter
    Fadle, Natalie
    Madjidi, Darius
    Neumann, Frank
    Bergeler, Lennart
    Graeber, Stefan
    Mueller, Cornelia S. L.
    Gruenhage, Frank
    Pfreundschuh, Michael
    Lammert, Frank
    Vogt, Thomas
    Pfoehler, Claudia
    PLOS ONE, 2013, 8 (03):
  • [3] Autoantibodies to CD28 in the Serum of Melanoma Patients have immunosuppressive Effects on T-cells
    Pfoehler, C.
    Koerner, R.
    Madjidi, D.
    Bergeler, L.
    Graeber, S.
    Pfreundschuh, M.
    Mueller, C. S. L.
    Vogt, T.
    Preuss, K-D
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 908 - 908
  • [4] Pannexin is a potential new target and prognostic marker for melanoma
    Lake, Francesca
    BIOMARKERS IN MEDICINE, 2012, 6 (05) : 638 - 638
  • [5] Pannexin: potential new target and prognostic marker for melanoma
    Lake, Francesca
    FUTURE ONCOLOGY, 2012, 8 (10) : 1221 - 1221
  • [6] Pannexin: potential new target and prognostic marker for melanoma
    Lake, Francesca
    EXPERT REVIEW OF PROTEOMICS, 2012, 9 (05) : 483 - 483
  • [7] Pannexin: a potential new target and prognostic marker for melanoma
    Lake, Francesca
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (10) : 1250 - 1250
  • [8] CD40 is a prognostic marker in primary cutaneous malignant melanoma
    vandenOord, JJ
    Maes, A
    Stas, M
    Nuyts, J
    Battocchio, S
    Kasran, A
    Garmyn, M
    DeWever, I
    DeWolfPeeters, C
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (06): : 1953 - 1961
  • [9] CD44 - A NEW PROGNOSTIC MARKER FOR NEUROBLASTOMA
    FAVROT, MC
    COMBARET, V
    LASSET, C
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (26): : 1965 - 1965
  • [10] ECP as prognostic Marker for Melanoma
    Moreira, A.
    Krueckel, A.
    Schuler, G.
    Utikal, J.
    Heinzerling, L.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 27 - 28
12345